Business Wire Feed

Global e·dentity™ Expands Landmark CRADA with DHS & TSA, Powered by President Trump’s Visionary Leadership to Secure America’s National Identity with Advanced Biometrics

April 15th, 2026|

CUPERTINO, Calif.--(BUSINESS WIRE)--Global e·dentity™ Inc., a Delaware-registered Service-Disabled Veteran-Owned Small Business (SDVOSB) and leader in advanced multi-factor biometric identity solutions, today announced a significant amendment (AM01) to its Cooperative Research and Development Agreement (CRADA No. more...

Ziff Davis to Announce First Quarter 2026 Earnings

April 15th, 2026|

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD) will release its First Quarter 2026 Earnings at 6:00PM ET on Thursday, May 7, 2026. Additionally, Ziff Davis invites the public, members of the press, the financial community, more...

Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026

April 13th, 2026|

Introductions span console electronics, quantitative NMR software, 80 MHz benchtop FT‑NMR, solid‑state and dissolution DNP, and automated protein and RNA workflows.ASILOMAR, Calif.--(BUSINESS WIRE)--$BRKR #BRKR--At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation (Nasdaq: BRKR) more...

Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy

April 13th, 2026|

Based on results from IDeate-Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trial If approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients RAHWAY, N.J.--(BUSINESS WIRE)--$MRK more...

PureTech Health: Notice of Results

April 13th, 2026|

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday, April 29, 2026. more...

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.